Axon Enterprise (AXON) Following Board Additions And A Fresh Undervalued Narrative

Board additions put governance in focus for Axon Enterprise

Axon Enterprise (AXON) has drawn fresh attention after appointing Vivek Mohindra and Eiso Kant as independent directors, with Mohindra joining key board committees and Kant observing the M&A and capital structure committee.

For investors watching Axon Enterprise stock, these appointments put board composition, oversight of financial reporting and future deal making in the spotlight rather than short term trading moves.

See our latest analysis for Axon Enterprise.

Axon Enterprise’s share price has pulled back recently. The 1 day share price return is 5.81% and the 7 day share price return is 9.81%. However, the 30 day share price return of 20.63% and 90 day share price return of 26.67% suggest momentum has been rebuilding, even as the year to date share price return is down 9.44%. Longer term total shareholder returns of 183.55% over three years and 178.80% over five years reflect a very different picture from the 1 year total shareholder return, which is down 32.51%.

If this governance update has you rethinking your watchlist, it could be a good moment to broaden your search with 53 AI infrastructure stocks

Axon Enterprise looks like a strong public safety technology business on the surface, but after the recent board changes and share price swings, is the current valuation still grounded in its fundamentals or running ahead of them?

Most Popular Narrative: 15.9% Undervalued

Axon Enterprise’s most followed narrative points to a fair value of $606.83 per share, compared with the last close at $510.28. This frames the new board appointments against a company that some investors already see as priced below its long term potential.

One company I find particularly interesting is Axon Enterprise. Many investors still associate the company primarily with TASER devices, but I think the more compelling part of the story is how Axon has quietly transformed itself into a software and data platform for public safety. What began as a hardware business is increasingly becoming an ecosystem built around digital evidence, cloud software, and connected policing tools.

Read the complete narrative.

Want to understand why this narrative still sees upside at today’s price? It focuses on sustained revenue growth, rising margins and a future profit multiple that would usually be reserved for mature software platforms. Curious which assumptions sit behind that fair value and how much of Axon Enterprise’s story rests on subscriptions rather than Tasers? The full narrative lays out the playbook.

Result: Fair Value of $606.83 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, Axon Enterprise’s story could be challenged if software adoption slows or public safety budgets tighten, which could limit demand for its broader platform beyond TASER devices.

Find out about the key risks to this Axon Enterprise narrative.

Another view on Axon Enterprise’s valuation

While the popular narrative pegs Axon Enterprise at a fair value of $606.83 per share, the SWS DCF model points to a future cash flow value of $454.88, below the current $510.28 share price. Instead of a discount, this framework suggests the stock is trading ahead of that estimate.

For investors comparing these two signals, the gap between a user narrative that sees Axon Enterprise as 15.9% undervalued and a DCF view that flags it as overvalued raises a simple question: which assumptions feel more realistic for long term cash generation and required returns?

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Axon Enterprise for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 47 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

With Axon Enterprise’s story balancing optimism and concern, it makes sense to move quickly, review the underlying data for yourself, and weigh both sides through the lens of 1 key reward and 3 important warning signs.

Looking for more Axon Enterprise sized ideas?

If Axon Enterprise has sharpened your focus, do not stop here. Broaden your opportunity set with fresh ideas that fit different goals and risk levels.

• Target potential mispricings by scanning companies that combine quality fundamentals with attractive valuations through our 47 high quality undervalued stocks.
• Strengthen your income stream by zeroing in on resilient payers with meaningful yields using the 8 dividend fortresses.
• Prioritise resilience and sleep-better-at-night holdings by focusing on companies with strong financial footing via the solid balance sheet and fundamentals stocks screener (47 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com